Clinical Research Center of New England - Foxboro

02/16/2026

Today, we honor the leaders who have shaped our country and the communities that make it strong. This Presidents’ Day, we celebrate the power of working together, supporting one another, and building a future we’re proud of.

02/13/2026

An early Alzheimer’s disease treatment trial is being conducted here at the Neurology Center of New England, and we are actively enrolling participants.

If you are interested in learning more about this research opportunity, please contact our research department at (781) 551-5812, option 6, or email researchNCNE@neurocenterne.com for additional details.

02/02/2026

01/30/2026

We’re excited to share that a new early Alzheimer's disease treatment trial is launching here at the Neurology Center of New England! We are still actively enrolling participants.

Please contact the research department at (781) 551-5812, option 6 or researchNCNE@neurocenterne.com for more information.

01/28/2026

We’re thrilled to congratulate Dr. Napoli for being named once again as one of Boston Magazine’s 2026 Top Doctors! 🎉

Dr. Napoli’s expertise spans comprehensive Multiple Sclerosis care, early diagnosis and treatment of Alzheimer’s Disease, and general neurology and research. Fellowship-trained in Multiple Sclerosis at the Brigham and Women’s/Harvard Medical Fellowship Program, he brings over 20 years of experience in MS care.

Dr. Napoli serves as Medical Director of the Neurology and Infusion Centers of New England and helps guide the center’s comprehensive neurology research program. Under his leadership, the Neurology Center of New England has also joined the National Multiple Sclerosis Society Partners in Care and the Alzheimer’s Network.

Thank you, Dr. Napoli, for your hard work and dedication!

01/27/2026

Do migraine attacks interfere with your quality of life?

The THRIVE Trial is now enrolling participants! People who take part may receive:

• Trial-related care from local doctors at no cost
• Trial medication at no cost

There is no obligation to participate, so see if you qualify now.

Please email ResearchNCNE@neurocenterne.com, call 781-551-5812 opt. 6, or visit https://bit.ly/430kY8d.

The THRIVE Trial is a clinical research study looking at people with migraine whose current medication to prevent it is not working well. See if you may qualify to help us learn more about medications to help prevent migraine attacks..

01/21/2026

This inspiring story of Fernando Mendoza celebrating with his mom, who is living with , highlights the resilience and strength of the MS .

Moments like these remind us why our work is so meaningful. Seeing our own patients and their families celebrate victories, big or small, is incredibly rewarding, and it’s uplifting to witness the triumphs of the broader community as well. 💙

Read more about their story: https://bit.ly/4sPqw0v.

“This is a dream come true.”

01/21/2026

A new early Alzheimer's disease treatment trial is launching at the Neurology Center of New England! Enrollment is currently open.

For more information or to see if this trial is right for you, please contact our research team at (781) 551-5812, option 6 or researchNCNE@neurocenterne.com.

01/19/2026

Today, we honor Martin Luther King Jr. and the timeless impact of his words, actions, and vision. His message of equality, justice, and compassion continues to inspire us to come together, support one another, and build stronger, more inclusive communities.

In our clinical research work, we are committed to these same values, ensuring that every individual has an equal opportunity to participate in trials, access cutting-edge treatments, and contribute to advancing medical knowledge for all.

01/17/2026

Meet Rachel O’Donnell!

Rachel oversees the Clinical Research Center of New England - Foxboro and plays a key role in coordinating focused on MS, Parkinson’s disease, Alzheimer’s disease, and migraine. Since joining the Neurology Center of New England in 2020, she has brought her expertise and passion for advancing neurological to every she oversees.

Rachel is dedicated to ensuring that every participant feels informed, supported, and valued throughout their clinical trial journey. We’re so grateful to have her on our team! 💙

01/16/2026

Are migraine attacks affecting your quality of life?

The THRIVE Trial is now enrolling participants! People who take part may receive:

• Trial-related care from local doctors at no cost
• Trial medication at no cost

There is no obligation to participate, so see if you qualify now.

Please email ResearchNCNE@neurocenterne.com, call 781-551-5812 opt. 6, or visit https://bit.ly/430kY8d.

The THRIVE Trial is a clinical research study looking at people with migraine whose current medication to prevent it is not working well. See if you may qualify to help us learn more about medications to help prevent migraine attacks..

01/14/2026

We’re excited to share that a new early Alzheimer's disease treatment trial is launching here at the Neurology Center of New England! We are actively enrolling!

Please contact the research department at (781) 551-5812 opt. 6 or researchNCNE@neurocenterne.com for more information.